Equity Investments, Drug Discovery & Development, Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C

Holding funds

Fair value and share of that fund's resolved holdings book, each at the fund's own most recent reported period — the as-of column, because the holders of one company do not file on one date. The bar under each fair value is that fund's share of the $1M combined total across every holder — a different denominator from the share-of-book column — so one dominant lender vs an even syndicate is visible without reading the dollar figures.